Invitrogen™ ELISA Kit for Human GDF15

Ref.: BL-RE-105938Manufacturer ref.: BMS2258 96 tests
€716.00 excl. VAT

L-ELISA of human GDF15 quantifies human GDF15 in serum, plasma, buffered solution or human cell culture medium. The dosage will recognize only natural and recombinant human GDF15. Principle of the L-ELISA method...

Accession number
Q99988
Dose range
2-125 pg/ml
Sensitivity of the dosage
0.59 pg/ml
Conjugate
Biotin
Product type
Kit ELISA
Brand
Invitrogen

L-ELISA of human GDF15 quantifies human GDF15 in serum, plasma, buffered solution or human cell culture medium. The dosage will recognize only natural and recombinant human GDF15. Principle of the L-ELISA method...

L-ELISA of human GDF15 quantifies human GDF15 in serum, plasma, buffered solution or human cell culture medium. The dosage will recognize only natural and recombinant human GDF15. L-ELISA solid phase sandwich principle of human GDF15 (immuno-enzymatic test) is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-vested in the wells of the supplied microplate. Samples, standards or controls are then added to these wells and bound to immobilized antibody (capture). The sandwich is formed by adding the second antibody (detector), a substrate solution that reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample. Rigorous validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.

Bone morphogenetic proteins (e.g., BMP5; MIM 112265) are members of the beta transformant growth factor superfamily (see TGF-beta1; MIM 190180) and regulate tissue differentiation and maintenance. They are synthesized as precursor molecules that are treated at a dibasic cleavage site to release C-terminal end domains containing a characteristic pattern of the 7 cysteins retained in the mature protein.

Sensitivity

Sensitivity of the dosage: 0.59 pg/ml.

Measurement range

Dose range: 2-125 pg/ml.

Duration of dosing

Total duration of dosing: 3 h 30 min.

Reproducibility

Coefficient of variation between doses 4.2%, interdose 2.9%.

Target

Target: Human.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)16362004
Specifications
Accession numberQ99988
Dose range2-125 pg/ml
Sensitivity of the dosage0.59 pg/ml
ConjugateBiotin
Product typeKit ELISA
Type of sampleSerum, Surnatant, Surnatant
Target speciesHuman
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)9518
Gene symbol(s)GDF15
Coefficient of inter-dose variation2.9%
Coefficient of intra-dose variation4.2%
Contents of kitsPre-coated well plate 96, Standard, sample diluent, dosing buffer concentrate, biotinylated detection antibodies, SAV-HRP, washing pad, chromogen, stop solution, adhesive film for plates
Marker or dyeHRP
Quantity96 tests
Regulatory statusRUO
TargetHuman
Test time1 h 20 min
Physical characteristics
Volume of samplePlasma, 10 μl; serum, 10 μl; supernatant, 10 μl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing3 h 30 min

Origin and customs

Manufacturer ref.BMS2258
Country of originAutriche
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.